World of DTC Marketing

OCTOBER 5, 2021

Seventy-nine percent of Americans think the price of prescription drugs is “unreasonable,” according to a 2019 Kaiser Family Foundation poll , and about 9 in 10 say they support the idea of the government negotiating prices. Via Axios “The 10 highest-selling drugs in the U.S.

Pharma 241

Pharma Insurance Sales Government 241

Integrity Solutions

DECEMBER 31, 2018

Here is some of our ‘Best of 2018’ content that can help fuel thoughts, discussions and strategies to make 2019 your best year yet. They have become increasingly more important- even becoming a competitive differentiator. We look forward to serving the world with integrity even more in 2019.

Sales Management 45

Sales Management Sales Ethics Management 45

World of DTC Marketing

JUNE 1, 2021

Since that time, Biogen’s MS drugs have faced intense competition as MS patients continue to vent on social media that the Biogen drug has nasty side effects. After the CEO departed the sinking ship, new management pinned all their hopes on the Biogen drug for Alzheimer’s.

FDA 187

FDA Side effects Patients Doctors 187

European Pharmaceutical Review

OCTOBER 5, 2022

The benefits of exposing students to the industry this way enables both parties to share knowledge, experience and provides students networking opportunities that can be difficult to obtain for such a competitive industry, said ABPI. It also found that The University of Bath, UK hosted the most industry placements: 61 in 2019 and 2022.

Pharma 104

Pharma Training Networking Pharmaceutical 104

European Pharmaceutical Review

JANUARY 16, 2023

In 2019, there were 40 million individuals with bipolar disorder worldwide. So, Rykindo ® will have to contend with the competition of other antipsychotic LAIs as treatments for psychosis disorders. Promising schizophrenia drug faces tough competition.

Food and Drug Administration 122

Food and Drug Administration FDA Competition Pharma 122

Referral MD

JULY 26, 2022

Since 2019, Press Ganey has gathered patient surveys to produce an annual report of what is driving them to pick one provider over another. And the findings are clear: Without a positive, up-to-date, and lively online presence, healthcare practices are falling behind and losing patients to the competition.

Healthcare 105

Healthcare Healthcare Healthcare Provider Competition 105

CloserIQ

FEBRUARY 1, 2019

“Despite the efforts of local colleges and universities, demand for tech workers has already outpaced supply, making competition fierce for the best software engineers, developers and data analysts, employers and educators said.” The post Weekly Roundup – Feb 4, 2019 appeared first on CloserIQ Blog.

Sales 45

Sales Training Prospecting Education 45

pharmaphorum

AUGUST 17, 2022

The latest life science competitiveness indicators (LSCIs) were published by the Office of Life Sciences (OLS) in July 2022. Indicators from the 2000s were captured in the Pharmaceutical Industry Competitiveness Task Force (PICTF) Indicators. The post UK life science competitiveness indicators 2022: measuring what matters most?

Competition 59

Competition Medicine Patients Government 59

Pharmaceutical Technology

MARCH 8, 2023

This is the second time Lilly has significantly reduced the cost of its insulin, as in 2019 the company reduced the list price of Humalog by 50%. These two insulin therapies have been off patent for about a decade but have a list price of about $500 for a pack of five injection pens and currently have limited competition from biosimilars.

Competition 105

Competition Insurance Leads Marketing 105

pharmaphorum

NOVEMBER 17, 2022

The 2019 VPAS , just like its predecessor that was in place from 2014, has at its heart a payback mechanism. That is why companies who are members of the 2019 VPAS have collectively paid back almost £3 billion to the Department of Health and Social Care (DHSC) up to Quarter 2 of 2022. Predictable for government. Variable for companies.

Government 98

Government Sales Medicine Consulting 98

CloserIQ

OCTOBER 16, 2019

In a hyper-competitive industry filled with giants, we need Millennials with superior sales acumen. The post Weekly Roundup – October 16, 2019 appeared first on CloserIQ. ” Inspire Your Millennial Salespeople to Sell with Passion (Danita Bye of SalesGravy). “The world of sales is extremely stressful.

Sales 40

Sales Prospecting Competition Sales Strategy 40

CloserIQ

OCTOBER 16, 2019

In a hyper-competitive industry filled with giants, we need Millennials with superior sales acumen. The post Weekly Roundup – October 16, 2019 appeared first on CloserIQ Blog. ” Inspire Your Millennial Salespeople to Sell with Passion (Danita Bye of SalesGravy). “The world of sales is extremely stressful.

Sales 40

Sales Prospecting Competition Sales Strategy 40

World of DTC Marketing

JANUARY 31, 2021

The cost of bringing a drug to market decreased from $2,168 million in 2018 to $1,981 in 2019. So where to start… Congresswoman Porter may want to look at the percentage of generic drugs available virus branded (89%). In pharma R&D returns have declined to 1.8 percent—a slight decrease of 0.1 percent from 2018. percent per year.

Pharma 187

Pharma Insurance Pharmaceutical Healthcare 187

pharmaphorum

NOVEMBER 16, 2022

Novartis completed the spin-out of Alcon in 2019, separating products like contact lenses and over-the-counter eyedrops from its prescription eye medicines, headed by age-related macular degeneration (AMD) blockbuster Lucentis (ranibizumab), which is partnered with Roche. billion in the first nine months of this year.

Sales 124

Sales Prescription Medicine Media 124

CloserIQ

OCTOBER 23, 2019

Successful sales leaders are competitive, energetic, driven, passionate, communicative, inspiring, etc. The post Weekly Roundup – October 23, 2019 appeared first on CloserIQ. We’ve compiled some of our favorite reads to help you advance in your sales career and build top sales teams. Featured Article.

Sales Strategy 40

Sales Strategy Sales Management Recruitment 40

CloserIQ

OCTOBER 23, 2019

Successful sales leaders are competitive, energetic, driven, passionate, communicative, inspiring, etc. The post Weekly Roundup – October 23, 2019 appeared first on CloserIQ Blog. We’ve compiled some of our favorite reads to help you advance in your sales career and build top sales teams. Featured Article.

Sales Strategy 40

Sales Strategy Sales Management Recruitment 40

CloserIQ

FEBRUARY 1, 2019

“Despite the efforts of local colleges and universities, demand for tech workers has already outpaced supply, making competition fierce for the best software engineers, developers and data analysts, employers and educators said.” The post Weekly Roundup – Feb 1, 2019 appeared first on CloserIQ Blog.

Sales 40

Sales Training Prospecting Education 40

European Pharmaceutical Review

JANUARY 2, 2024

Pharma pushes for UK medicine scheme revision Drug pricing was considered as the most negative emerging regulatory and macroeconomic trend, impeding growth for the industry, based on GlobalData’s 2019, 2020, 2021, and 2022 industry outlooks.

Pharma 102

Pharma Medicine Marketing Government 102

Healthcare Success

DECEMBER 6, 2022

In this blog, I share nine healthcare marketing trends you need to embrace in 2023 to remain competitive in today’s ever-changing healthcare marketplace. Competition from Retail and Telehealth Disruptors Continues to Intensif y. The COVID-19 pandemic supercharged a new type of competition for legacy healthcare organizations.

Healthcare 113

Healthcare Healthcare Marketing Competition 113

Integrity Solutions

MARCH 30, 2020

Those business plans were created in Q4 2019, a quarter that started with the continuation of the greatest period of economic expansion and stock market growth in history. What kinds of questions were company leaders asking during that last quarter of 2019 when those 2020 plans were being put together?

Sales 83

Sales Competition Ethics Marketing 83

European Pharmaceutical Review

JANUARY 29, 2024

SPC manufacturing waiver Aims and challenges First enacted in 2019, the goal of the SPC manufacturing waiver is to enable the manufacture of medicines, under certain conditions, during the up-to-five-year extension of the market protection of certain patented medicinal products in the EU, Medicines for Europe summarised.

Medicine 98

Medicine Manufacturing Competition Marketing 98

Pharmaceutical Technology

SEPTEMBER 15, 2022

According to GlobalData’s report, Coronavirus Disease 2019 (Covid-19) Analyst Consensus Sales Analysis and Forecast, H1 2022 , Comirnaty is the leading prophylactic Covid-19 vaccine and recorded sales of $41.3bn in 2021. AbbVie reported a 22.7% Bristol Myers Squibb (BMS) documented a 9.1%

Sales 108

Sales Competition Pharmaceutical Pharmaceutical research 108

European Pharmaceutical Review

AUGUST 25, 2023

Haruvi added that Tyruko has the potential to extend the reach of natalizumab treatment for these patients and “fuel innovation through competition in the market”. In 2019, Sandoz entered into a global commercialisation agreement for Tyruko with Polpharma Biologics.

Food and Drug Administration 98

Food and Drug Administration FDA Distribution Food 98

Pharmaceutical Technology

JANUARY 30, 2023

For 2019–23, this was capped at 2% per year. During 2019–21, when sales being close to predicted levels resulted in single-digit payback rates, the scheme was relatively popular with the pharma sector.

Government 97

Government Pharma Sales Medicine 97

pharmaphorum

JANUARY 3, 2023

Side-effect data from the open-label studies was also encouraging, helping to downplay concerns abut evenamide’s cardiovascular and central nervous system safety that emerged in 2019. ” The new data could accelerate partnering efforts of the drug this year.

Side effects 105

Side effects Biopharma Patients Competition 105

European Pharmaceutical Review

JUNE 8, 2023

A new report by the Association of the British Pharmaceutical Industry (ABPI) has identified the UK biopharma industry is increasingly seeking talent with artificial intelligence (AI) and data skills to maintain competitiveness as digital technology continues to drive innovation. This has spiked from 27 in 2019 to 225 in 2022.

Biopharma 98

Biopharma Government Training Education 98

European Pharmaceutical Review

SEPTEMBER 13, 2023

As small and medium-sized enterprises (SMEs) often face unfair competition when doing business in Europe, through the (SME) Relief Communication, the European Commission (EC) has proposed new measures to provide short-term relief, boost long-term competitiveness, and improve equality in the business environment across the Single Market in Europe.

Pharma 96

Pharma Competition Marketing Training 96

pharmaphorum

JANUARY 24, 2023

Since 2010, the UK has fallen from 4th to 98th place in overall trade balance in pharmaceuticals, due to fierce global competition, according to the MMIP. Medicines and medical technology manufacturing delivered annual exports worth over £30 billion ($37 billion) for the UK in 2019, on top of making a £32.1 It’s not all bad news.

Manufacturing 111

Manufacturing Medicine Government Pharmaceutical manufacturing 111

pharmaphorum

AUGUST 26, 2022

BioMarin will no doubt have an eye on the earlier experience of bluebird bio, which secured EU approval for rare disease gene therapy Zynteglo (betibeglogene autotemcel) in 2019 for beta thalassaemia with a price tag of around €1.6 million spread over five years.

Marketing 111

Marketing FDA Competition Patients 111

pharmaphorum

DECEMBER 15, 2022

of total sales – under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) introduced in 2019. Next year we must start again with a clean sheet of paper to agree on what an internationally competitive scheme looks like.” billion (around $4 billion) in revenue to the government – 26.5% VPAS tax on top. .

Pharma 72

Pharma Government Manufacturing Medicine 72

PM360

SEPTEMBER 12, 2023

In 2019, Urhekar took charge of Ashfield Health as its Global President where he drove substantial growth and galvanized internal teams and leaders under a single vision, simplifying the internal structure to ensure the smoother delivery of client work. “FH FH is at an exciting time in its evolution,” said Urhekar.

Networking 98

Networking Recruitment Consulting Marketing 98

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 98

Medicine Healthcare Healthcare Pharma 98

pharmaphorum

JANUARY 13, 2023

California Attorney General Rob Bonta (pictured above) said the conduct of the companies amounts to unlawful and deceptive business practices that violate the state’s unfair competition laws. The suit follows legal action over insulin pricing taken by other states, including Arkansas , Kansas, Mississippi, and Minnesota.

Manufacturing 105

Manufacturing Patients Medical Competition 105

Sales Talent

FEBRUARY 7, 2020

2019 Sales Hiring in Review. In our 2019 forecast we shared Former Federal Reserve Chairman Alan Greenspan’s observation of employment in the United States in late 2018. Things were even tighter at the end of 2019. in Dec 2019. in Dec 2019. According to the BLS, as of Oct 2019, there were 5.8M

Sales 52

Sales B2B Sales Recruitment Marketing 52

Clarivate

DECEMBER 7, 2021

The previously clear lines between sectors are blurring and the competitive set is widening. Trademarks filed by LVMH that mention AR/VR in 2019 were more than double compared to the previous year, according to our trademark research data. Louis Vuitton developed a game, Louis, to target a Generation Z demographic. [3]

Professional Services 95

Professional Services Management Competition Sales 95

European Pharmaceutical Review

JUNE 24, 2022

However, a Gupta study from 2019 on what companies spend money on when developing new drugs showed that out?of?pocket He focuses his practice on EU regulatory affairs, litigation and competition law issues affecting the life sciences sector in Europe. Maarten has significant competition law experience in a variety of sectors.

Pharmaceutical 105

Pharmaceutical Medicine Marketing Competition 105

Pharmaceutical Technology

DECEMBER 5, 2022

Overall, Aurinia’s Lupkynis is expected to face tough competition from Benlysta in LN, which received FDA approval in December 2020 and EMA approval in May 2021. Notably, Lupkynis is the first oral therapy approved by the US Food and Drug Administration (FDA) and EC for the treatment of active LN.

Food and Drug Administration 59

Food and Drug Administration Physicians Competition FDA 59